Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL28135389 | 0.81 | TSHR (0.61) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL8981952 | 0.81 | TSHR (0.61) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL10524269 | 0.81 | TSHR (0.61) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL616647 | 0.80 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL3722218 | 0.80 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL1035999 | 0.80 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL5142182 | 0.80 | TSHR (0.89) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL3886594 | 0.79 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL9422022 | 0.79 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL3886591 | 0.79 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107431244-B | Electrolyte for lithium secondary battery and lithium secondary battery comprising same | 三星SDI株式会社 | 2020-04-03 | — | — | CN | claimed |
| US-10601068-B2 | Electrolyte for lithium secondary battery and lithium secondary battery comprising same | SAMSUNG SDI CO., LTD. (KR) | 2020-03-24 | — | — | US | claimed |
| EP-3240092-B1 | LITHIUM SECONDARY BATTERY COMPRISING A SPECIFIC ELECTROLYTE | SAMSUNG SDI CO LTD (KR) | 2019-09-25 | — | — | EP | claimed |
| US-20170358814-A1 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY COMPRISING SAME | SAMSUNG SDI CO., LTD. (KR) | 2017-12-14 | — | — | US | claimed |
| CN-107431244-A | Electrolyte for lithium secondary battery and the lithium secondary battery comprising it | 三星SDI株式会社 | 2017-12-01 | — | — | CN | claimed |
| EP-3240092-A1 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY COMPRISING SAME | Samsung SDI Co., Ltd. (KR) | 2017-11-01 | — | — | EP | claimed |
| WO-2016001129-A1 | IMPROVED INSECTICIDAL COMPOSITIONS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-01-07 | — | — | WO | claimed |
| EP-2587922-A1 | IMPROVED INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES | Bayer Intellectual Property GmbH (DE) | 2013-05-08 | — | — | EP | claimed |
| CN-103079407-A | Improved insecticidal compositions comprising cyclic carboximidamidines | BAYER CROPSCIENCE AG | 2013-05-01 | — | — | CN | claimed |
| US-20120004268-A1 | INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES | BAYER CROPSCIENCE AG (DE) | 2012-01-05 | — | — | US | claimed |
| WO-2012000902-A1 | IMPROVED INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES | BAYER CROPSCIENCE AG (DE) | 2012-01-05 | — | — | WO | claimed |
| EP-4720206-A1 | INVISIBLE FLUORESCENT SOLVENT INK JET INK COMPOSITIONS | Videojet Technologies, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| US-20260062581-A1 | INVISIBLE FLUORESCENT SOLVENT INK JET INK COMPOSITIONS | VIDEOJET TECHNOLOGIES INC. (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4655359-A1 | SOFT PIGMENTED CONTINUOUS INK JET INK COMPOSITIONS | Videojet Technologies, Inc. (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20250346772-A1 | SOFT PIGMENTED CONTINUOUS INK JET INK COMPOSITIONS | VIDEOJET TECHNOLOGIES INC. (US) | 2025-11-13 | — | — | US | disclosed |
| US-4885396-A | REACTING 2,4-DIHYDROXYBENZOPHENONE WITH ETHYLENE CARBONATE IN PRESENCE OF QUATERNARY AMMONIUM CATALYST | BASF AKTIENGESELLSCHAFT (DE) | 1989-12-05 | — | — | US | disclosed |
| EP-0340408-A1 | Process for the preparation of 2-hydroxy-4-(2'-hydroxyethoxy)-benzophenones | BASF Aktiengesellschaft (DE) | 1989-11-08 | — | — | EP | disclosed |
| EP-0159294-B1 | PROCESS FOR PREPARING CYCLIC PHOSPHOROUS-ACID ESTERS | CIBA-GEIGY AG (CH) | 1988-11-17 | — | — | EP | disclosed |
| US-4692540-A | Process for the preparation of cyclic phosphites | CIBA-GEIGY CORPORATION (US) | 1987-09-08 | — | — | US | disclosed |
| EP-0159294-A2 | Process for preparing cyclic phosphorous-acid esters | CIBA-GEIGY AG (CH) | 1985-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062581-A1 | INVISIBLE FLUORESCENT SOLVENT INK JET INK COMPOSITIONS | SRC, NLRP1, NLRP3 | TSHR 4579/4885NFKB1 1735/4885KCNA1 3478/4885 |
| US-10601068-B2 | Electrolyte for lithium secondary battery and lithium secondary battery comprising same | AS3MT, TST, SETDB1 | TSHR 2668/4885NFKB1 2006/4885KCNA1 162/4885 |
| US-20120004268-A1 | INSECTICIDAL COMPOSITIONS COMPRISING CYCLIC CARBONYLAMIDINES | DDT, PRMT9, PNISR | TSHR 2612/4885NFKB1 1573/4885KCNA1 380/4885 |
| US-20170358814-A1 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY COMPRISING SAME | AS3MT, TST, SETDB1 | TSHR 2668/4885NFKB1 2006/4885KCNA1 162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.